Diampromide
From Wikipedia, the free encyclopedia
|
Diampromide
|
|
| Systematic (IUPAC) name | |
| N-[2-(methyl-(2-phenylethyl)amino)propyl]-N-phenylpropanamide | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C21H28N2O |
| Mol. mass | 324.46 g/mol |
| SMILES | & |
| Synonyms | Diampromide |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Diampromide is an opioid analgesic from the ampromide family of drugs, related to other drugs such as propiram. It was invented in the 1960s, and can be described as a ring-opened analogue of fentanyl.[1]
Diampromide produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea, and is around the same potency as morphine.[1]
[edit] References
- ^ Ivanovic MD, Micovic IV, Vuckovic S, Prostran M, Todorovic Z, Ivanovic ER, Kiricojevic VD, Djordjevic JB, Dosen-Micovic LJ. The synthesis and pharmacological evaluation of 2,3-seco-fentanyl analogues. Journal of the Serbian Chemical Society. 2004; 69(11): 955-968.

